152 related articles for article (PubMed ID: 35406529)
1. Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
Gyllensten U; Hedlund-Lindberg J; Svensson J; Manninen J; Öst T; Ramsell J; Åslin M; Ivansson E; Lomnytska M; Lycke M; Axelsson T; Liljedahl U; Nordlund J; Edqvist PH; Sjöblom T; Uhlén M; Stålberg K; Sundfeldt K; Åberg M; Enroth S
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406529
[TBL] [Abstract][Full Text] [Related]
2. High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer.
Enroth S; Berggrund M; Lycke M; Broberg J; Lundberg M; Assarsson E; Olovsson M; Stålberg K; Sundfeldt K; Gyllensten U
Commun Biol; 2019; 2():221. PubMed ID: 31240259
[TBL] [Abstract][Full Text] [Related]
3. A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer.
Enroth S; Berggrund M; Lycke M; Lundberg M; Assarsson E; Olovsson M; Stålberg K; Sundfeldt K; Gyllensten U
Clin Proteomics; 2018; 15():38. PubMed ID: 30519148
[TBL] [Abstract][Full Text] [Related]
4. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
5. A multiplex platform for the identification of ovarian cancer biomarkers.
Boylan KLM; Geschwind K; Koopmeiners JS; Geller MA; Starr TK; Skubitz APN
Clin Proteomics; 2017; 14():34. PubMed ID: 29051715
[TBL] [Abstract][Full Text] [Related]
6. Validation of candidate serum ovarian cancer biomarkers for early detection.
Su F; Lang J; Kumar A; Ng C; Hsieh B; Suchard MA; Reddy ST; Farias-Eisner R
Biomark Insights; 2007 Oct; 2():369-75. PubMed ID: 19662218
[TBL] [Abstract][Full Text] [Related]
7. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
[TBL] [Abstract][Full Text] [Related]
8. Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.
Leung F; Dimitromanolakis A; Kobayashi H; Diamandis EP; Kulasingam V
Clin Biochem; 2013 Oct; 46(15):1462-8. PubMed ID: 23528302
[TBL] [Abstract][Full Text] [Related]
9. Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment.
Enroth S; Ivansson E; Lindberg JH; Lycke M; Bergman J; Reneland A; Stålberg K; Sundfeldt K; Gyllensten U
Commun Med (Lond); 2022; 2():124. PubMed ID: 36196264
[TBL] [Abstract][Full Text] [Related]
10. Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics.
Wang W; Xie H; Xia B; Zhang L; Hou Y; Li K
J Cancer; 2021; 12(6):1651-1659. PubMed ID: 33613752
[No Abstract] [Full Text] [Related]
11. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer.
Weiland F; Lokman NA; Klingler-Hoffmann M; Jobling T; Stephens AN; Sundfeldt K; Hoffmann P; Oehler MK
Front Oncol; 2020; 10():1767. PubMed ID: 33102207
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer.
Lokman NA; Ricciardelli C; Stephens AN; Jobling TW; Hoffmann P; Oehler MK
Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33406648
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine.
Sandow JJ; Rainczuk A; Infusini G; Makanji M; Bilandzic M; Wilson AL; Fairweather N; Stanton PG; Garama D; Gough D; Jobling TW; Webb AI; Stephens AN
Proteomics Clin Appl; 2018 May; 12(3):e1700135. PubMed ID: 29426060
[TBL] [Abstract][Full Text] [Related]
15. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer.
Zhang Z; Bast RC; Yu Y; Li J; Sokoll LJ; Rai AJ; Rosenzweig JM; Cameron B; Wang YY; Meng XY; Berchuck A; Van Haaften-Day C; Hacker NF; de Bruijn HW; van der Zee AG; Jacobs IJ; Fung ET; Chan DW
Cancer Res; 2004 Aug; 64(16):5882-90. PubMed ID: 15313933
[TBL] [Abstract][Full Text] [Related]
16. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection.
Cirillo PDR; Margiotti K; Fabiani M; Barros-Filho MC; Sparacino D; Cima A; Longo SA; Cupellaro M; Mesoraca A; Giorlandino C
PLoS One; 2021; 16(8):e0255804. PubMed ID: 34352040
[TBL] [Abstract][Full Text] [Related]
17. Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type 2.
Marcišauskas S; Ulfenborg B; Kristjansdottir B; Waldemarson S; Sundfeldt K
J Proteomics; 2019 Mar; 196():57-68. PubMed ID: 30710757
[TBL] [Abstract][Full Text] [Related]
18. The preclinical natural history of serous ovarian cancer: defining the target for early detection.
Brown PO; Palmer C
PLoS Med; 2009 Jul; 6(7):e1000114. PubMed ID: 19636370
[TBL] [Abstract][Full Text] [Related]
19. [Ascites May Provide Useful Information for Diagnosis of Ovarian Cancer].
Stuchlíková E; Zahradníková M; Nenutil R; Valík D; Vojtěšek B; Novotný M; Hernychova L
Klin Onkol; 2017; 30(Supplementum1):187-190. PubMed ID: 28471203
[TBL] [Abstract][Full Text] [Related]
20. Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer.
Lim R; Lappas M; Riley C; Borregaard N; Moller HJ; Ahmed N; Rice GE
J Ovarian Res; 2013 Jan; 6(1):5. PubMed ID: 23339669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]